Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients.
about
Consensus on the role of human cytomegalovirus in glioblastomaAltered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.Identification of inhibitors for a virally encoded protein kinase by 2 different screening systems: in vitro kinase assay and in-cell activity assay.Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivoMultifocal bacterial osteomyelitis in a renal allograft recipient following urosepsisSubclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.Herpesvirus infections in organ transplant recipientsCytomegalovirus in solid organ transplantation.Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection.Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques.Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.Epigenetic control of cytomegalovirus latency and reactivation.Impairment of cytomegalovirus-specific cellular immune response as a risk factor for cytomegalovirus disease in transplant recipients.Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.Rhesus CMV: an emerging animal model for human CMV.Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation.Activation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner.Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope proteinImpact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.Strategies for managing cytomegalovirus in transplant recipients.Cytomegalovirus-associated renal allograft rejection: new challenges for antiviral preventive strategies.Is HCMV a tumor promoter?Viral surveillance and subclinical viral infection in pediatric kidney transplantation.Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.The risk factors for cytomegalovirus reactivation following stem cell transplantation.Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells.High human cytomegalovirus DNAemia early post-transplantation associates with irreversible and progressive loss of renal function - a retrospective study.Late onset epstein barr virus seropositive posttransplant lymphoproliferative disorder in two renal transplant receivers.Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo.Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences.Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients.Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients.Anemia as very late-onset cytomegalovirus disease after kidney transplantation.Cytomegalovirus-specific regulatory and effector T cells share TCR clonality--possible relation to repetitive CMV infections.Clinical relevance of cytomegalovirus viraemia(*,†).Renal Ischemia/Reperfusion Injury Activates the Enhancer Domain of the Human Cytomegalovirus Major Immediate Early Promoter
P2860
Q24632103-00E2A4A3-C360-4D90-9562-D6FACC08D58EQ30438204-188090DF-4EED-4D3D-BD62-E0DBFAA3EFD2Q30453768-77F64654-8E57-4B7D-9439-9BE17CEDEED1Q31146602-EC08F128-03C0-4BC3-A45C-383F05176A62Q33725662-EE056180-5468-4C84-A009-1BBDB1BC85A0Q34024335-5444A44D-E920-4D48-8F7C-07E9032A4E83Q34455315-54C5080A-4C1F-4D17-A08B-1DEB694041B9Q34579836-06CB8249-19B9-4423-AFB9-E5CEF9992FE1Q34583491-0636F52F-32AD-43CE-B2A8-735B3CE1FDA1Q34779037-F5DEFED7-0B88-426F-9963-79C9061B1342Q35150896-F8A9BEDF-96F0-4A4E-BA90-A8149D132C9AQ36728782-DC6C9F9F-F7D1-411E-B7EC-218EEBDA0492Q37015743-9FCF79B0-0E92-4FFB-98A4-D4CFC9A94814Q37024817-7DAE29E6-51D4-4AAE-809F-885A899CB6E2Q37026155-49E53618-C85D-4561-BDF7-A10306DE6397Q37056384-CB482F85-997F-436E-8864-CEE160D2B828Q37081669-913A7EAD-E410-4519-88D1-75F61E12BEFAQ37254205-E6CB1DB7-450A-4D63-9890-D7FA6C1EC782Q37519151-495E1D51-E4BB-46F8-9C23-6B2D839E35D0Q37652611-58C2DCB5-F6D2-4120-A88C-AB1AA2BCEAF1Q37773992-B2101FCD-355B-4B01-B19A-AA08194EF9D1Q37778827-4F20BD0A-C855-4682-8595-93723DFE724DQ37805181-DFECC981-A3CD-4439-B391-AB14B1F8FF0AQ38240085-5BB3A033-8549-4D22-89C5-4DE49077425BQ38377602-245F65E6-C43F-4F8A-ADB6-E56EB6D23682Q38751030-B515A003-60C9-4E34-AB8D-54C02B7A6D46Q38960892-0A086881-57C2-448E-84C5-AA8392933B9AQ40232106-DBC3CB71-526F-4E43-9B52-870EB5CF2DB4Q41846519-7EC1CE49-8C3A-447A-8D6A-7294B70FD74AQ41894147-4E961963-77BB-4C74-80AE-997815BF2C32Q45353014-51320A30-B204-4422-B4DE-6425C67FE12EQ46043095-514E11E5-31F2-4145-8CCE-EF9E0A3353A9Q46618896-A7AAF4D3-39B1-441E-93EC-D863D24ACFB7Q48138605-2CCE2D8D-DF31-4EA3-B222-37E7AE7040ECQ52891818-EFE6E03C-0B4E-4E1A-8736-D030B56BCBB1Q54391854-B2553E58-C436-4448-8EAC-A1DEB7E257CAQ58071696-7A4BDC00-88E0-4241-843F-1C0919C4B83E
P2860
Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mechanisms of human cytomegalo ...... on organ transplant patients.
@ast
Mechanisms of human cytomegalo ...... on organ transplant patients.
@en
Mechanisms of human cytomegalovirus
@nl
type
label
Mechanisms of human cytomegalo ...... on organ transplant patients.
@ast
Mechanisms of human cytomegalo ...... on organ transplant patients.
@en
Mechanisms of human cytomegalovirus
@nl
prefLabel
Mechanisms of human cytomegalo ...... on organ transplant patients.
@ast
Mechanisms of human cytomegalo ...... on organ transplant patients.
@en
Mechanisms of human cytomegalovirus
@nl
P2093
P2860
P1476
Mechanisms of human cytomegalo ...... t on organ transplant patients
@en
P2093
P2860
P304
P356
10.1034/J.1399-3062.1999.010304.X
P50
P577
1999-09-01T00:00:00Z